Holen Sie sich die Stockscreener-App
10.00
9.09%
-1.00
Finanzdaten der Briacell Therapeutics Corp-Aktie (BCTX)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-04-30 | 2025-01-31 | 2024-10-31 | 2024-07-31 | 2024-04-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
11.73%
6.3283
|
7.1694 | 5.1528 | 5.768 | 9.2296 |
| Depreciation and Amortization |
0.0267
|
- | - | - | 0.00382 |
| Operating Income/Loss |
11.73%
-6.3283
|
-7.1694 | -5.1528 | -5.768 | -9.2296 |
| Nonoperating Income/Loss |
114.49%
-0.00976
|
0.0674 | 0.0117 | -23.67 | 10.96 |
| Income/Loss Before Equity Method Investments |
2.11%
-6.1622
|
-6.2952 | -5.7578 | - | - |
| Income/Loss From Equity Method Investments |
47.33%
-0.0627
|
-0.0426 | -0.0715 | - | - |
| Income/Loss From Continuing Operations Before Tax |
1.78%
-6.2249
|
-6.3378 | -5.8293 | 8.6143 | 1.6922 |
| Income/Loss From Continuing Operations After Tax |
1.78%
-6.2249
|
-6.3378 | -5.8293 | 8.6143 | 1.6922 |
|
Net Income/Loss
|
1.78%
-6.2249
|
-6.3378 | -5.8293 | -1.2488 | 1.6922 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | 0.1401 | - |
| Attributable To Noncontrolling Interest |
111.23%
-0.098
|
-0.0464 | -0.0271 | -0.0346 | -0.0235 |
| Basic Average Shares |
38.37%
3.7355
|
2.6996 | 26.64 | 0.4732 | 15.98 |
| Diluted Average Shares |
38.37%
3.7355
|
2.6996 | 26.64 | 0.4732 | 15.98 |
| Basic Earnings Per Share |
29.61%
-1.64
|
-2.33 | -0.22 | -0.07 | 0.11 |
| Diluted Earnings Per Share |
29.61%
-1.64
|
-2.33 | -0.22 | -0.07 | 0.11 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | 0.1401 | - |
0.64%
0.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):